Edition:
United Kingdom

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

77.74USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$77.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
176,520
52-wk High
$79.57
52-wk Low
$38.43

Chart for

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximatel... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $3,415.65
Shares Outstanding(Mil.): 58.06
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.60
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-Insulet Corp Posts Q4 Loss Per Share $0.12

* INSULET REPORTS FOURTH QUARTER REVENUE OF $130.5 MILLION, UP 26%, AND GROSS MARGIN UP 210 BASIS POINTS, EXCEEDING EXPECTATIONS

21 Feb 2018

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT

09 Jan 2018

BRIEF-Insulet announces pricing of convertible senior notes due 2024

* Insulet announces pricing of convertible senior notes due 2024

08 Nov 2017

BRIEF-Insulet announces private offering of convertible senior notes

* Insulet announces private offering of convertible senior notes

06 Nov 2017

BRIEF-Insulet Corp reports Q3 loss per share $0.04

* Q3 revenue $121.8 million versus I/B/E/S view $114.4 million

02 Nov 2017

BRIEF-Insulet says $100 mln investment in Massachusetts will provide for hundreds of local jobs

* Says $100 million investment in Massachusetts will provide for hundreds of local manufacturing jobs at a 350,000 square-foot facility

28 Sep 2017

Competitors

Earnings vs. Estimates